PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 133 filers reported holding PDL BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $37,000 | -43.1% | 12,700 | -44.5% | 0.03% | -48.3% |
| Q1 2020 | $65,000 | -16.7% | 22,900 | -4.2% | 0.06% | +1.7% |
| Q4 2019 | $78,000 | +59.2% | 23,900 | +4.4% | 0.06% | +78.8% |
| Q3 2019 | $49,000 | +81.5% | 22,900 | +94.1% | 0.03% | +450.0% |
| Q1 2017 | $27,000 | +12.5% | 11,800 | +4.4% | 0.01% | +20.0% |
| Q4 2016 | $24,000 | – | 11,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |